Zobrazeno 1 - 10
of 1 469
pro vyhledávání: '"Hoffman MT"'
Autor:
Dilly J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hoffman MT; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Abbassi L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Paradiso F; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Parent BD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Hennessey CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Jordan AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Morgado M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dasgupta S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Uribe GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Hambitzer FP; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Qiang L; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Feng H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Geisberg J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Evans KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lyu H; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Schalck A; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng N; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lopez AM; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bristow CA; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kim MP; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rajapakshe KI; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bahrambeigi V; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roth JA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Garg K; Exact Sciences, Redwood City, California., Guerrero PA; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Stanger BZ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Cristea S; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard School of Public Health, Boston, Massachusetts., Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York., Baslan T; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mancias JD; Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chan E; Amgen Inc., Thousand Oaks, California., Anderson A; Amgen Inc., Thousand Oaks, California., Katlinskaya YV; Amgen Inc., Thousand Oaks, California., Shalek AK; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts.; Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Hong DS; University of Texas M.D. Anderson Cancer Center, Houston, Texas., Pant S; University of Texas M.D. Anderson Cancer Center, Houston, Texas., Hallin J; Mirati Therapeutics Inc., San Diego, California., Anderes K; Mirati Therapeutics Inc., San Diego, California., Olson P; Mirati Therapeutics Inc., San Diego, California., Heffernan TP; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chugh S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Christensen JG; Mirati Therapeutics Inc., San Diego, California., Maitra A; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Nowak JA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Winter PS; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Dougan SK; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Nov 01; Vol. 14 (11), pp. 2135-2161.
Autor:
Xu EJK, Smith BE, Conce Alberto WD, Walsh MJ, Lim B, Hoffman MT, Qiang L, Dong J, Garmilla A, Zhao QH, Perez CR, Gaglione SA, Dobson CS, Dougan M, Dougan SK, Birnbaum ME
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 22. Date of Electronic Publication: 2024 Sep 22.
Autor:
Holden P; African Climate and Development Initiative, University of Cape Town, Cape Town, South Africa.; Plant Conservation Unit, Department of Biological Sciences, University of Cape Town, Cape Town, South Africa., Anderson M; African Climate and Development Initiative, University of Cape Town, Cape Town, South Africa.; Environmental and Geographical Science, University of Cape Town, Cape Town, South Africa., Eckardt F; Environmental and Geographical Science, University of Cape Town, Cape Town, South Africa., Ziervogel G; African Climate and Development Initiative, University of Cape Town, Cape Town, South Africa.; Environmental and Geographical Science, University of Cape Town, Cape Town, South Africa., Jack SL; Plant Conservation Unit, Department of Biological Sciences, University of Cape Town, Cape Town, South Africa., New MG; African Climate and Development Initiative, University of Cape Town, Cape Town, South Africa.; Environmental and Geographical Science, University of Cape Town, Cape Town, South Africa., Smit J; Department of Civil Engineering and Geomatics, Cape Peninsula University of Technology (CPUT), Cape Town, South Africa., Visser M; School of Economics, University of Cape Town, Cape Town, South Africa., Hoffman MT; Plant Conservation Unit, Department of Biological Sciences, University of Cape Town, Cape Town, South Africa.
Publikováno v:
Conservation biology : the journal of the Society for Conservation Biology [Conserv Biol] 2024 Jun; Vol. 38 (3), pp. e14285. Date of Electronic Publication: 2024 Apr 30.
Autor:
Salas-Escabillas DJ; Cancer Biology, University of Michigan, Ann Arbor, MI.; Department of Surgery, Henry Ford Health, Detroit, MI., Hoffman MT; Department of Immunology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Moore JS; Department of Surgery, Henry Ford Health, Detroit, MI., Brender SM; Department of Surgery, Henry Ford Health, Detroit, MI., Wen HJ; Department of Surgery, Henry Ford Health, Detroit, MI., Benitz S; Department of Surgery, Henry Ford Health, Detroit, MI., Davis ET; Department of Surgery, Henry Ford Health, Detroit, MI., Long D; Department of Surgery, Henry Ford Health, Detroit, MI., Wombwell AM; Department of Surgery, Henry Ford Health, Detroit, MI., Steele NG; Department of Surgery, Henry Ford Health, Detroit, MI., Sears RC; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR., Matsumoto I; Monell Chemical Senses Center, Philadelphia, PA., DelGiorno KE; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN., Crawford HC; Department of Surgery, Henry Ford Health, Detroit, MI.; Cancer Biology Program, Wayne State University, Detroit, MI.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 23. Date of Electronic Publication: 2024 Apr 23.
Autor:
Gillson L; Plant Conservation Unit, Department of Biological Sciences, University of Cape Town, Cape Town, South Africa; From May 2024: Leverhulme Centre for Anthropocene Biodiversity, University of York, York YO10 5DD, UK. Electronic address: lindsey.gillson@uct.ac.za., Hoffman MT; Plant Conservation Unit, Department of Biological Sciences, University of Cape Town, Cape Town, South Africa., Gell PA; Future Regions Research Centre, Federation University, Ballarat, Australia., Ekblom A; University of Uppsala, Uppsala, Sweden., Bond WJ; Department of Biological Sciences, University of Cape Town, Cape Town, South Africa.
Publikováno v:
Trends in ecology & evolution [Trends Ecol Evol] 2024 Apr; Vol. 39 (4), pp. 359-367. Date of Electronic Publication: 2023 Dec 21.
Publikováno v:
African Journal of Range and Forage Science; Vol. 40 No. 1 (2023); 1-19
The persistent spread of shrublands is a global phenomenon observed across semiarid grassland-shrubland boundaries. Observations in South Africa, however, have detected a contrasting trend of increasing grass cover across the transition between the N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5528f77c7d83aa01057fbb58a848ef24
Autor:
Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ali LR; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Horick N; Massachusetts General Hospital, Boston, Massachusetts, USA., Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Metayer KA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Murray S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Goessling W; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Wisch JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Mouw K; Harvard Medical School, Boston, Massachusetts, USA., Reardon B; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zerillo JA; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Clark JW; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Parikh A; Massachusetts General Hospital, Boston, Massachusetts, USA., Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Schlechter B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Kumar S; Naveris, Inc, Waltham, Massachusetts, USA., Del Vecchio Fitz C; Naveris, Inc, Waltham, Massachusetts, USA., Kuperwasser C; Naveris, Inc, Waltham, Massachusetts, USA., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Coveler AL; University of Washington School of Medicine, Seattle, Washington, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Welsh EL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pfaff K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jan 25; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 25.
Autor:
Kureshi R; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Bello E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA., Kureshi CTS; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Walsh MJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA., Lippert V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Hoffman MT; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Dougan M; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA., Longmire T; Bristol Myers Squibb, Cambridge, MA, USA., Wichroski M; Bristol Myers Squibb, Cambridge, MA, USA., Dougan SK; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Science advances [Sci Adv] 2023 Nov 24; Vol. 9 (47), pp. eadk1853. Date of Electronic Publication: 2023 Nov 24.
Autor:
Qiang L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Castillo JI; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kageler L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Temesgen A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Lenehan P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bello E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Uribe GA; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yang A; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Aguirre AJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Raghavan S; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Pelletier M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts., Cremasco V; Novartis Institute for Biomedical Research, Cambridge, Massachusetts., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts. Electronic address: stephanie_dougan@dfci.harvard.edu.
Publikováno v:
Gastroenterology [Gastroenterology] 2023 Oct; Vol. 165 (4), pp. 874-890.e10. Date of Electronic Publication: 2023 May 30.
Autor:
Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Jun 02; Vol. 13 (6), pp. 1288-1290.